Pharmaceutics formulation/chemistry manufacturing and controls consulting services for small molecules and/or biologics
Ended Purchase Order Awarded Last action
- Contract number
- 75N95025P00440
- Awardee
-
RPK Associates, LLC UEI LVQSZ4JZE4V3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $108,000
Award facts
- Opportunity
-
- Subject Matter Expert Consultant for Pharmaceutics / Formulation / Chemistry Manufacturing Control [CMC] Solicitation · 75N95025Q00057 · Posted Aug 8, 2025
- Contract value 78% obligated
- $138,000.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 10 offers Simplified Acquisition
- Pricing
- Labor Hours
- Place of performance
- Brookeville, MD 20833, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $54,000 | |
| Original award | $54,000 |
About this award
The National Institute of Neurological Disorders and Stroke awarded a purchase order to RPK Associates, LLC, a small business, for $138,000 on September 29, 2025, to provide pharmaceutics formulation and chemistry manufacturing and controls consulting services for small molecules and biologics in support of NIH Blueprint Neurotherapeutics and HEAL drug development programs. The order is set aside for total small business and structured as a labor-hour purchase order with a ceiling value of $138,000. Performance occurs in Brookeville, Maryland, with occasional on-site visits to NIH facilities in Bethesda, Maryland. The engagement requires subject matter expert consulting on drug development processes, regulatory risk evaluation, manufacturing strategy recommendations, and regulatory documentation support through participation in development team meetings. The option year one period of performance extends through September 28, 2027.
Quick answers
Who was awarded contract 75N95025P00440?
75N95025P00440 was awarded to RPK Associates, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 29, 2025.
How much is contract 75N95025P00440 worth?
The government has obligated $108,000 on 75N95025P00440. Its current value, with exercised options, is $138,000.
Which agency awarded contract 75N95025P00440?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95025P00440, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Was contract 75N95025P00440 competed?
The extent of competition for 75N95025P00440 was competed under sap. The government received 10 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award